(Q38351124)

2 September 2017

Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease (English)

1 reference

2 September 2017

0 references

Paradisi R

1

1 reference

2 September 2017

Venturoli S

2

1 reference

2 September 2017

Pasquali R

3

1 reference

2 September 2017

Capelli M

4

1 reference

2 September 2017

Porcu E

5

1 reference

2 September 2017

Fabbri R

6

1 reference

2 September 2017

Flamigni C

7

1 reference

2 September 2017

1 April 1986

1 reference

Journal of Endocrinological Investigation

2 September 2017

1 reference

2 September 2017

9

1 reference

2 September 2017

2

1 reference

2 September 2017

139-144

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03348085

2 September 2017

0 references

cites work

The polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03348085

Abnormal luteinizing hormone response patterns to synthetic gonadotrophin releasing hormone in patients with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348085

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348085

The functional changes of the pituitary gonadotrophs during the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348085

beta-Endorphin and beta-lipotropin plasma levels in hirsute women: correlation with body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348085

Radioimmunoassay of Plasma Dehydroepiandrosterone Sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348085

[Hypothalamic -hypophyseal functional activity in amenorrhea. Comparison between GnRH stimulation response and the results of discriminative analysis of basal hormonal levels]

21 January 2018

1 reference

12 December 2020

Pituitary response to bolus and continuous intravenous infusion of luteinizing hormone-releasing factor in normal women and women with polycystic ovarian syndrome

1 reference

12 December 2020

The polycystic ovary. I. Clinical and histologic features

1 reference

12 December 2020

Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome

1 reference

12 December 2020

Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.

1 reference

12 December 2020

Radioimmunoassay of three oestrogens and three androgens in the same plasma sample after extraction and chromatographic separation

1 reference

12 December 2020

Obesity and its role in polycystic ovary syndrome

1 reference

12 December 2020

Ultrasonic findings in polycystic ovarian disease

1 reference

12 December 2020

Endocrine comparison of obese menstruating and amenorrheic women

1 reference

12 December 2020

Gonadotropin Levels and Secretory Patterns in Patients with Typical and Atypical Polycystic Ovarian Disease

1 reference

12 December 2020

Elevated plasma levels of β-endorphin in a group of women with polycystic ovarian disease

1 reference

12 December 2020

Pituitary gonadotropin responses to synthetic luteinizing hormone-releasing hormone in patients with typical and atypical polycystic ovary disease

1 reference

12 December 2020

Gonadotropin profiles in fed and fasted obese women

1 reference

12 December 2020

Abnormal sex steroid secretion and binding in massively obese women

1 reference

12 December 2020

Significance of 17alpha OH progesterone assay in the evaluation of ovarian and adrenal function

1 reference

12 December 2020

The diagnostic significance of LH-releasing hormone test in patients with amenorrhea

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03348085

1 reference

2 September 2017

1 reference